BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18288207)

  • 1. Factors influencing retention of adenovirus within tumours following direct intratumoural injection.
    Bazan-Peregrino M; Carlisle RC; Purdie L; Seymour LW
    Gene Ther; 2008 May; 15(9):688-94. PubMed ID: 18288207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice.
    Crettaz J; Berraondo P; Mauleón I; Ochoa-Callejero L; Shankar V; Barajas M; van Rooijen N; Kochanek S; Qian C; Prieto J; Hernández-Alcoceba R; González-Aseguinolaza G
    Hepatology; 2006 Sep; 44(3):623-32. PubMed ID: 16941711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus.
    Green NK; Herbert CW; Hale SJ; Hale AB; Mautner V; Harkins R; Hermiston T; Ulbrich K; Fisher KD; Seymour LW
    Gene Ther; 2004 Aug; 11(16):1256-63. PubMed ID: 15215884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
    Yoon SK; Armentano D; Wands JR; Mohr L
    Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53.
    Lipinski KS; Djeha AH; Krausz E; Lane DP; Searle PF; Mountain A; Wrighton CJ
    Gene Ther; 2001 Feb; 8(4):274-81. PubMed ID: 11313801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
    Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
    Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
    J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
    Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice.
    Li H; Lu H; Griscelli F; Opolon P; Sun LQ; Ragot T; Legrand Y; Belin D; Soria J; Soria C; Perricaudet M; Yeh P
    Gene Ther; 1998 Aug; 5(8):1105-13. PubMed ID: 10326034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
    Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
    Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H
    Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver.
    Tao N; Gao GP; Parr M; Johnston J; Baradet T; Wilson JM; Barsoum J; Fawell SE
    Mol Ther; 2001 Jan; 3(1):28-35. PubMed ID: 11162308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial.
    Stewart AK; Lassam NJ; Quirt IC; Bailey DJ; Rotstein LE; Krajden M; Dessureault S; Gallinger S; Cappe D; Wan Y; Addison CL; Moen RC; Gauldie J; Graham FL
    Gene Ther; 1999 Mar; 6(3):350-63. PubMed ID: 10435085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
    Lambright ES; Amin K; Wiewrodt R; Force SD; Lanuti M; Propert KJ; Litzky L; Kaiser LR; Albelda SM
    Gene Ther; 2001 Jun; 8(12):946-53. PubMed ID: 11426335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration.
    Kuriyama S; Yoshiji H; Nakai S; Deguchi A; Uchida N; Kimura Y; Inoue H; Kinekawa F; Ogawa M; Nonomura T; Masaki T; Kurokohchi K; Watanabe S
    Oncol Rep; 2005 Jan; 13(1):69-74. PubMed ID: 15583804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced growth in response to ganciclovir treatment of subcutaneous xenografts expressing HSV-tk in the vascular compartment.
    Mavria G; Porter CD
    Gene Ther; 2001 Jun; 8(12):913-20. PubMed ID: 11426331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.
    Lee CT; Park KH; Yanagisawa K; Adachi Y; Ohm JE; Nadaf S; Dikov MM; Curiel DT; Carbone DP
    Cancer Res; 2004 Sep; 64(18):6660-5. PubMed ID: 15374981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
    Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
    Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.